Delivery Order SPE2DB22D1202-SPE2DB24FUKR3
Award Date 12/18/23
Potential Completion Date 12/19/23
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,286.88, to provide RAMELTEON 8 MG TABLET 100S to the government. The contract has an ultimate completion date of July 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,347.17, is a Delivery Order to supply RAMELTEON 8 MG TABLET UD 50S, a generic medication. The contract has an ultimate completion date of December 1, 2023 and utilizes a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.37 firm fixed-price delivery order is for the supply of RAMELTEON 8 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of June 10, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,478.04 fixed-price delivery order is for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product, with a completion date of July 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, with an ID of SPE2DB22D3009 | SPE2DB25FAP83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $3,508.08, is a Delivery Order for the supply of 4,567,074,312 units of the medication RAMELTEON 8 MG TABLET 100S. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. This appears to be a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide RAMELTEON 8MG TAB 30S, a prescription medication. The contract has a ceiling value of $1,344.48 and a completion date of May 20, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award, SPE2DB22D3401|SPE2DB24FT4XB, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $1,148.04 delivery order is for the supply of RAMELTEON 8 MG TABLET 30S medication. The contract has a firm fixed price and an ultimate completion date of September 26, 2024. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop...
- This federal contract award, valued at $2,681.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RAMELTEON 8 MG TABLET 30S, a prescription medication, with a period of performance through March 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RAMELTEON 8 MG TABLET 30S. The contract has a ceiling value of $1,543.74 and will run through August 20, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support military treatment...
- This federal contract award is a delivery order valued at $1,865.82 issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product, with a period of performance through September 11, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts by various defense and civilian...